Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Alessi

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Diabete & Metabolisme|July 1, 1987
Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1I Juhan-Vague, P Vague, M C Alessi, et al.
Biophysical Journal|June 1, 1993
Granulocyte-endothelium initial adhesion. Analysis of transient binding events mediated by E-selectin in a laminar shear flowG Kaplanski, C Farnarier, O Tissot, et al.
Diabetes|August 3, 2000
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesityM C Alessi, D Bastelica, P Morange, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriersP E Morange, M Henry, D Tregouët, et al.
Thrombosis and Haemostasis|October 1, 1995
Resistance to activated protein C--diagnostic strategy in a laboratory of haemostasisM F Aillaud, E Succo, M C Alessi, et al.
Clinical Rheumatology|September 1, 1992
Lupus anticoagulant in silica-induced sclerodermaJ M Durand, M F Aillaud, G Kaplanski, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1989
Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activatorI Juhan-Vague, J M Stassen, M C Alessi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000
Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factorsI Juhan-Vague, J F Renucci, M Grimaux, et al.
Thrombosis and Haemostasis|June 30, 1986
Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with ageM F Aillaud, F Pignol, M C Alessi, et al.
The European Respiratory Journal|August 1, 1995
Fibrinolytic and inflammatory processes in pleural effusionsF Philip-Joët, M C Alessi, C Philip-Joët, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Diabete & Metabolisme|July 1, 1987
Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1I Juhan-Vague, P Vague, M C Alessi, et al.
Biophysical Journal|June 1, 1993
Granulocyte-endothelium initial adhesion. Analysis of transient binding events mediated by E-selectin in a laminar shear flowG Kaplanski, C Farnarier, O Tissot, et al.
Diabetes|August 3, 2000
Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesityM C Alessi, D Bastelica, P Morange, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriersP E Morange, M Henry, D Tregouët, et al.
Thrombosis and Haemostasis|October 1, 1995
Resistance to activated protein C--diagnostic strategy in a laboratory of haemostasisM F Aillaud, E Succo, M C Alessi, et al.
Clinical Rheumatology|September 1, 1992
Lupus anticoagulant in silica-induced sclerodermaJ M Durand, M F Aillaud, G Kaplanski, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1989
Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activatorI Juhan-Vague, J M Stassen, M C Alessi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000
Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factorsI Juhan-Vague, J F Renucci, M Grimaux, et al.
Thrombosis and Haemostasis|June 30, 1986
Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with ageM F Aillaud, F Pignol, M C Alessi, et al.
The European Respiratory Journal|August 1, 1995
Fibrinolytic and inflammatory processes in pleural effusionsF Philip-Joët, M C Alessi, C Philip-Joët, et al.
Pageof 15